Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease.

Calverley PM et al.·The New England Journal of Medicine·Feb 2007·PMID 17314337

Authors' conclusion

Mixed

Does not affect the score

Publi-Score

C

51/100

NuancedLast updated: 4/18/2026

Fidelity

Abstract only65% concordance × 24/26 subcriteria

Category breakdown

Total raw score49.3/100

Integrity coefficient

A. Authors' integrity

COI declaration

0.40

Funding independence

0.70

Coeff. authors = avg(0.40, 0.70) = 0.55

B. Editorial process

Peer review

1.00

Submission→accept. delay

0.90

Coeff. editorial = avg(1.00, 0.90) = 0.95

min(0.55, 0.95) = 0.55← lowest dominates

🚫

Alert signal : eoc → Coefficient forced to 0.3

Expression of Concern published

Final coefficient : 0.55

Final score = 49.3/52.8 × 0.55 × 100 = 51/100

Save

📄 Export PDF

|

Share

PubMed DOI

Twitter/X LinkedIn

Contribute

Actions

Analyze another article View the methodology

Information

PMID: 17314337
DOI

10.1056/NEJMoa063070

Mode

🔬 Partial AI (abstract)

Grid

v1.1

Scored on

4/18/2026